Read our most recent insights for people with diabetes and healthcare professionals.
Post-DTM 2024: Orange Biomed’s Key Takeaways and Future Plans
Discover Orange Biomed’s journey and innovations in diabetes technology after the Diabetes Technology Meeting 2024, focusing on health equity and solutions.
Innovations in A1C Testing: What’s Happening at the Diabetes Technology Meeting 2024
Explore innovations in A1C testing at the Diabetes Technology Meeting 2024. Learn about Orange Biomed’s OBM rapid A1c and its impact on equitable diabetes care.
ADA 84th Scientific Sessions and Post Conference Forum Recap – New POC A1C Test and Additional Innovative Solutions Unveiled
Stay Informed Ahead of the Next Diabetes Conference in 2025. The ADA’s (American Diabetes Association) 84th Scientific Sessions, held from June 21–24 in Orlando, Florida, showcased breakthrough research and discussions
Orange Biomed to Present a Revolutionary New Method of A1c Testing at ADA 2024 – Preview Before Public Release
Learn How The Microfluidic Technology In OBM rapid A1c, A New At-Home Device For Monitoring HbA1C, Can Generate Lab-Accurate Results From A Single Drop of Blood For More Accessible And
5 Important Women in STEM Making Strides in Diabetes Care and Advocacy in 2024
5 Women Making Strides in Diabetes Care and Advocacy in 2023. Women’s History Month may be over, but that…
Orange Biomed to Attend MEDICA & Diabetes Technology Meeting to Spread Awareness of A1c Testing Gaps
Seattle, WA, October 30, 2023—Orange Biomed—a healthcare startup with cutting-edge diabetes management technology—announced their attendance at major industry events: Diabetes Technology Meeting and MEDICA. Orange Biomed is a medical device
Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings
Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings The United States is home to many cultural and ethnic diversity. With this comes recognition of
ADA 2023 Recap – New Method of A1c Testing for Better Diabetes Management and Diagnosis and More
The 83rd ADA 2023 Scientific Sessions occurred from June 23 – 26th in San Diego, California this year. Many industry leaders and innovators attended this year’s conference to address the
ADA 2023 Preview – New Method of A1c Testing for Better Diabetes Management and Diagnosis
The 83rd ADA 2023 Scientific Sessions will be taking place on June 23 – 26th in San Diego, California this year.
Load More
Post-DTM 2024: Orange Biomed’s Key Takeaways and Future Plans
Discover Orange Biomed’s journey and innovations in diabetes technology after the Diabetes Technology Meeting 2024, focusing on health equity and solutions.
Innovations in A1C Testing: What’s Happening at the Diabetes Technology Meeting 2024
Explore innovations in A1C testing at the Diabetes Technology Meeting 2024. Learn about Orange Biomed’s OBM rapid A1c and its impact on equitable diabetes care.
ADA 84th Scientific Sessions and Post Conference Forum Recap – New POC A1C Test and Additional Innovative Solutions Unveiled
Stay Informed Ahead of the Next Diabetes Conference in 2025. The ADA’s (American Diabetes Association) 84th Scientific Sessions, held from June 21–24 in Orlando, Florida, showcased breakthrough research and discussions
Orange Biomed to Present a Revolutionary New Method of A1c Testing at ADA 2024 – Preview Before Public Release
Learn How The Microfluidic Technology In OBM rapid A1c, A New At-Home Device For Monitoring HbA1C, Can Generate Lab-Accurate Results From A Single Drop of Blood For More Accessible And
5 Important Women in STEM Making Strides in Diabetes Care and Advocacy in 2024
5 Women Making Strides in Diabetes Care and Advocacy in 2023. Women’s History Month may be over, but that…
Orange Biomed to Attend MEDICA & Diabetes Technology Meeting to Spread Awareness of A1c Testing Gaps
Seattle, WA, October 30, 2023—Orange Biomed—a healthcare startup with cutting-edge diabetes management technology—announced their attendance at major industry events: Diabetes Technology Meeting and MEDICA. Orange Biomed is a medical device
Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings
Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings The United States is home to many cultural and ethnic diversity. With this comes recognition of
ADA 2023 Recap – New Method of A1c Testing for Better Diabetes Management and Diagnosis and More
The 83rd ADA 2023 Scientific Sessions occurred from June 23 – 26th in San Diego, California this year. Many industry leaders and innovators attended this year’s conference to address the
ADA 2023 Preview – New Method of A1c Testing for Better Diabetes Management and Diagnosis
The 83rd ADA 2023 Scientific Sessions will be taking place on June 23 – 26th in San Diego, California this year.
